GSL Healthcare, Inc. entered into an agreement to acquire Agentix Corp. (OTCPK:AGTX) in a reverse merger transaction for CAD 0.84 million on May 28, 2020. Under the terms of agreement, Agentix Corp. issued 27.932271 million shares of common stock in consideration for all of the issued and outstanding shares of common stock of GSL Healthcare. The effect of the issuance is that former two GSL Healthcare shareholders now hold approximately 88% of the issued shares of common stock of Agentix Corp. Until such time as Agentix Corp can formulate GSL Healthcare's general business plan, it is not changing its current business. Upon closing, Faisal Joseph shall be appointed Chairman of the Board of Directors, Riazul Huda shall be appointed a Director and the Treasurer of Agentix, and Rudy Mazzocchi shall be appointed a director and, President, Chief Executive Officer, and Secretary of Agentix. The deal is subject to all necessary approvals under federal and state securities laws; Agentix obtaining an opinion stating that the terms of the exchange are fair, just and equitable to Agentix and its shareholders; satisfactory due diligence; Agentix shall have received a written resignation from each of the directors and officers of GSL Healthcare effective as of the closing; among others. The deal is expected to close on or before June 30, 2020.

GSL Healthcare, Inc. completed the acquisition of Agentix Corp. (OTCPK:AGTX) in a reverse merger transaction on June 1, 2020. Prior to the exchange, 3.806613 million shares of Agentix remained outstanding as part of the merger.